Windlas Biotech (NSE:WINDLAS) Inventory Turnover: 2.38 (As of Mar. 2026)


NSE:WINDLAS Windlas Biotech Ltd NSE:WINDLAS
90 GF Score
Price ₹853.95
GF Value ₹940.03
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Windlas Biotech Inventory Turnover?

Windlas Biotech NSE:WINDLAS -0.51% 90 Inventory Turnover is 2.38 as of Mar. 2026. GuruFocus rates NSE:WINDLAS with a GF Score™ of 90/100 and a GF Value™ of ₹940.03 (Fairly Valued). The stock has 1 warning sign investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Windlas Biotech's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹1,471 Mil. Windlas Biotech's Average Total Inventories for the quarter that ended in Mar. 2026 was ₹618 Mil. Windlas Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.38.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Windlas Biotech's Days Inventory for the three months ended in Mar. 2026 was 38.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Windlas Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.26.

Windlas Biotech  (NSE:WINDLAS) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Windlas Biotech's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=618.24/1470.51*365 / 4
=38.36

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Windlas Biotech's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=618.24 / 2384.99
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Windlas Biotech Inventory Turnover Related Terms

Windlas Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Windlas Biotech's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Windlas Biotech Inventory Turnover Chart

Windlas Biotech Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventory Turnover
Get a 7-Day Free Trial 6.05 4.88 5.79 6.57 7.78

Windlas Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 1.59 1.95 2.04 2.38
NSE:WINDLAS
90GF Score
Windlas Biotech Ltd NSE:WINDLAS
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Windlas Biotech Inventory Turnover Calculation

Windlas Biotech's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Inventory Turnover (A: Mar. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Mar. 2026 ) / ((Total Inventories (A: Mar. 2025 ) + Total Inventories (A: Mar. 2026 )) / count )
=5572.34 / ((813.84 + 618.24) / 2 )
=5572.34 / 716.04
=7.78

Windlas Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover (Q: Mar. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2026 ) / ((Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count )
=1470.51 / ((0 + 618.24) / 1 )
=1470.51 / 618.24
=2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 2.38 mean?
Windlas Biotech (NSE:WINDLAS) has a Inventory Turnover of 2.38 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Windlas Biotech and its competitors.
Is Windlas Biotech's Inventory Turnover too high?
Windlas Biotech's current Inventory Turnover is 2.38. Overall, Windlas Biotech has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Windlas Biotech's Inventory Turnover compare to ZTS and UTHR?
Windlas Biotech's Inventory Turnover of 2.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Drug Manufacturers company?
A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Windlas Biotech and its competitors. Windlas Biotech's current Inventory Turnover is 2.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Windlas Biotech stock overvalued right now?
Based on GuruFocus' analysis, Windlas Biotech (NSE:WINDLAS) is currently considered Fairly Valued. The stock's GF Value™ is ₹940.03, compared to a current price of ₹853.95 — trading 9.2% below its estimated fair value. The current Inventory Turnover is 2.38. Windlas Biotech's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Windlas Biotech (NSE:WINDLAS), the current Inventory Turnover is 2.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Windlas Biotech (NSE:WINDLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Windlas Biotech stock appears to be undervalued. The current stock price of ₹853.95 is trading 9.2% below its estimated GF Value™ of ₹940.03. GuruFocus considers Windlas Biotech to be Fairly Valued.

Key valuation signals for NSE:WINDLAS:

  • Inventory Turnover: 2.38
  • GF Value™: ₹940.03 vs. price of ₹853.95 (9.2% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the NSE:WINDLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Windlas Biotech Business Description

Other Exchanges 543329:India
Address Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
90GF Score

Get the complete analysis for NSE:WINDLAS

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹853.95
Price
₹940.03
GF Value